Young ESUS Patient Registry "Y-ESUS"

Recruiting

Phase N/A Results N/A

Trial Description

This study seeks to determine the clinical characteristics of young ESUS patients using diagnostic criteria of the Cryptogenic Stroke / ESUS International Working Group, and to determine the rates of stroke recurrence, death, and hospital readmission in a contemporary cohort of young ESUS patients during follow-up of up to 18 months.

Conditions

Trial Population

Patients presenting to hospital-based stroke unit with an ESUS Stroke

Outcomes

Type Measure Time Frame Safety Issue
Primary Recurrent ischemic stroke and/or death in a well-defined Young ESUS cohort Approximately 18 Months
Secondary Recurrent ischemic stroke in a well-defined Young ESUS cohort Approximately 18 Months
Secondary Prevalence of Patent Foramen Ovale in a well-defined Young ESUS cohort Baseline

Sponsors